A novel autophagy‐related lncRNA survival model for lung adenocarcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A novel autophagy‐related lncRNA survival model for lung adenocarcinoma

Published:2021-05-13 Issue:12 Volume:25 Page:5681-5690
ISSN:1582-1838
Container-title:Journal of Cellular and Molecular Medicine
language:en
Short-container-title:J Cell Mol Med

Author:

Wu Liwei¹^ORCID,Wen Zilu²,Song Yanzheng¹³,Wang Lin¹

Affiliation:

1. Department of Thoracic Surgery Shanghai Public Health Clinical CenterFudan University Shanghai China

2. Department of Scientific Research Shanghai Public Health Clinical CenterFudan University Shanghai China

3. TB Center Shanghai Emerging & Re‐emerging Infectious Diseases Institute Shanghai China

Publisher

Wiley

Subject

Cell Biology,Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcmm.16582

Reference28 articles.

1. Lung cancer: current therapies and new targeted treatments

2. The burden of lung cancer in Latin-America and challenges in the access to genomic profiling, immunotherapy and targeted treatments

3. Lobectomy for non-small cell lung carcinoma: a nationwide study of short- and long-term survival

4. Prognostic and predictive factors in patients with brain metastases from solid tumors: A review of published nomograms

5. Inflammatory signaling cascades and autophagy in cancer

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cellular Senescence-Related Long Non-coding RNA Signatures Predict Prognosis in Juvenile Osteosarcoma;Phenomics;2024-07-08

2. A novel long non-coding RNA WASIR2 regulates MEX3A expression by sponging miR-374b-5p and promotes lung adenocarcinoma progression;2024-04-04

3. Sense and anti-sense: Role of FAM83A and FAM83A-AS1 in Wnt, EGFR, PI3K, EMT pathways and tumor progression;Biomedicine & Pharmacotherapy;2024-04

4. A novel immune-related long noncoding RNA (lncRNA) pair model to predict the prognosis of triple-negative breast cancer;Translational Cancer Research;2024-03

5. Regulation of overexpression lncRNA ATP2B1-AS1 on lung adenocarcinoma progression;Journal of Cardiothoracic Surgery;2024-02-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3